Clinical Trial Update: Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating combined minocycline and lovastatin for Fragile X syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• minocycline + lovastatin (combined therapy)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED